Key Highlights
- Subscription fees received fell to USD 23.9 million in the third quarter from USD 30.9 million, and to USD 74.6 million for nine months from USD 103.6 million.
- Amwell (NYSE:AMWL) reported fees from its affiliated medical group visits of USD 23.7 million, up from USD 21.2 million in the third quarter, and USD 77.0 million for nine months.
- The platform supported about 2.7 million virtual care visits in the nine months ended September 30, 2026, and about 40.3 million since inception.
- A listed risk is whether the Defense Health Agency relationship continues beyond the fourth quarter of 2026 on comparable financial terms.
Subscription Fees Decline as Clinical Visit Fees Grow
Amwell (NYSE:AMWL) filed its Form 10-Q for the quarter ended September 30, 2026 on November 3, 2026. The filing says subscription fees received were USD 23.9 million, against USD 30.9 million in the third quarter of 2025, a drop of about 23% by simple arithmetic. For nine months, subscription fees were USD 74.6 million against USD 103.6 million, about 28% lower. Fees from visits delivered by its affiliated medical group, AMG, moved the other way, rising to USD 23.7 million from USD 21.2 million, about 12% higher, and to USD 77.0 million for nine months from USD 70.6 million. The extract reviewed stops before the income statement, so total revenue, net loss and cash are not stated here.
How the Platform Earns Subscription and Fee-for-Service Revenue
Amwell sells its enterprise digital care platform on a subscription basis, typically under contracts of three years, with longer terms for the largest strategic clients. A health plan contract usually includes a recurring fee based on the number of members with access, plus add-on program fees, so subscription Revenue moves with covered lives and programs. Separately, the affiliated medical group earns fee-for-service amounts for each episode of care across specialties such as family medicine, psychiatry, therapy and nutrition. Professional services and Carepoint devices for hospital and home use make up the remaining offerings. As of December 31, 2025, it served about 50 health plans covering over 90 million lives and about 80 large health systems.
Client Concentration, Government Contract and Other Risks to Watch
The filing lists a history of losses and the risk that profitability is not achieved among its factors. It also cites a limited number of significant clients, weak growth and Volatility in the digital care market, competition from existing and new entrants, and slower-than-expected adoption by patients and clients. Management points to its ability to commence and complete strategic transformation initiatives and to the continuation of the Defense Health Agency relationship beyond the fourth quarter of 2026 with comparable financial terms. Seasonal viruses can also complicate forecasting. Privacy rules and Cybersecurity Liability remain a regulatory exposure, since the platform handles personal health information.
Where Things Stand
Subscription fees fell because the Business is receiving less recurring platform income than a year ago, while clinical visit fees from its medical group grew. Amwell (NYSE:AMWL) did not provide, in the part of the filing reviewed, the revenue, loss or cash figures needed to judge whether the mix shift helps or hurts overall results. The decline in subscription fees is steep, and the Defense Health Agency relationship, client concentration and the outcome of its transformation initiatives are the items the filing itself highlights. Investors will want to see the full financial statements and any commentary on contract renewals.






Please wait processing your request...